As reported by BDS Analytics, consumer spending on cannabis-based foods and beverages reached an estimated $1 billion in 2017 in the U.S. and Canada—and is projected to grow to more than $4.1 billion in those countries by 2022.

The FDA recently held a hearing designed to include information and views related to the safety of cannabis edibles and beverages—with a strong emphasis on cannabidiol (CBD) ingredients—as well as to solicit input relevant to the agency's regulatory strategy for existing products.

While records of medical and therapeutic use of cannabis go back thousands of years, several points in history proved instrumental to furthering the ongoing body of research.

While more U.S. states continually pass recreational and medical cannabis legislation, opening the door to use of cannabis for personal and health-related reasons, from a national perspective, regulatory authorities lack a centralized, cohesive structure.

To continue to better serve the market for legal cannabis edibles and beverages, Cannabis Products is expanding its market presence.